Literature DB >> 31207360

Lipidomics in autoimmune diseases with main focus on systemic lupus erythematosus.

Helena Beatriz Ferreira1, Ana Margarida Pereira2, Tânia Melo3, Artur Paiva4, M Rosário Domingues5.   

Abstract

Autoimmune diseases (AID) are a heterogeneous group of disorders that have in common a chronic inflammation and dysregulation of the immune system. Systemic lupus erythematosus (SLE) is one of the most frequent systemic autoimmune diseases characterized by autoimmune phenomena in multiple organs. The tests used for evolution and prognosis assessment are either non-specific or non-sensitive, impairing an adequate therapeutics. To face this drawback, lipidomics is being used to provide more knowledge and insights regarding autoimmune disorders. Through lipidomic approaches using MS, it is possible to identify and quantify the level of lipid molecular species in the biological system and this could be useful to identify biomarkers and to better understand the pathophysiology of autoimmune diseases. There are some evidence that lipids and oxidized lipids can play a key role in AID pathogenesis. Although this field has been scarcely explored, there are some studies that reported variations on the lipid profile at a molecular level using lipidomic approaches based on MS in SLE. The results gathered herein showed changes mainly in the level of phospholipids, with decrease of some plasmenyl lipids, fatty acids, with reduction of PUFA, and sphingolipids, with changes in fatty acyl chain composition. These changes may be the result of lipids` modifications due to oxidation and increase of ROS. Some alterations can be associated with changes in membrane of lymphocytes and with the deregulation of the immune system. Thus, exploring the knowledge from modern lipidomic approaches in the study of the role of lipids and oxidized lipids, in oxidative stress and in inflammatory diseases, could contribute for the identification of new lipid biomarkers. Lipid biomarkers are promising tools to prognosis and treatment monitoring, tailored for the best therapeutic response and highest safety to ensure better patient care and to be used for personalized medicine.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Autoimmune diseases; Biomarkers; Lipid peroxidation; Lipidomics; Mass spectrometry; Systemic lupus erythematosus

Year:  2019        PMID: 31207360     DOI: 10.1016/j.jpba.2019.06.005

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  7 in total

1.  Omega-3 fatty acid intake suppresses induction of diverse autoantibody repertoire by crystalline silica in lupus-prone mice.

Authors:  Lichchavi D Rajasinghe; Quan-Zhen Li; Chengsong Zhu; Mei Yan; Preeti S Chauhan; Kathryn A Wierenga; Melissa A Bates; Jack R Harkema; Abby D Benninghoff; James J Pestka
Journal:  Autoimmunity       Date:  2020-09-09       Impact factor: 2.957

Review 2.  Functional Lipids in Autoimmune Inflammatory Diseases.

Authors:  Michele Dei Cas; Gabriella Roda; Feng Li; Francesco Secundo
Journal:  Int J Mol Sci       Date:  2020-04-27       Impact factor: 5.923

Review 3.  Assessment and management of the heightened risk for atherosclerotic cardiovascular events in patients with lupus erythematosus or dermatomyositis.

Authors:  Emily Keyes; Madison Grinnell; Douglas Jacoby; Thomas Vazquez; DeAnna Diaz; Victoria P Werth; Kevin Jon Williams
Journal:  Int J Womens Dermatol       Date:  2021-09-09

4.  Silica Induction of Diverse Inflammatory Proteome in Lungs of Lupus-Prone Mice Quelled by Dietary Docosahexaenoic Acid Supplementation.

Authors:  Lichchavi D Rajasinghe; Melissa A Bates; Abby D Benninghoff; Kathryn A Wierenga; Jack R Harkema; James J Pestka
Journal:  Front Immunol       Date:  2022-01-21       Impact factor: 7.561

Review 5.  Centrality of Myeloid-Lineage Phagocytes in Particle-Triggered Inflammation and Autoimmunity.

Authors:  Olivia K Favor; James J Pestka; Melissa A Bates; Kin Sing Stephen Lee
Journal:  Front Toxicol       Date:  2021-11-04

Review 6.  Lipidomics in Understanding Pathophysiology and Pharmacologic Effects in Inflammatory Diseases: Considerations for Drug Development.

Authors:  Kabir Ahluwalia; Brandon Ebright; Kingsley Chow; Priyal Dave; Andrew Mead; Roy Poblete; Stan G Louie; Isaac Asante
Journal:  Metabolites       Date:  2022-04-07

7.  Plasma lipidomics of monozygotic twins discordant for multiple sclerosis.

Authors:  Horst Penkert; Chris Lauber; Mathias J Gerl; Christian Klose; Markus Damm; Dirk Fitzner; Andrea Flierl-Hecht; Tania Kümpfel; Martin Kerschensteiner; Reinhard Hohlfeld; Lisa A Gerdes; Mikael Simons
Journal:  Ann Clin Transl Neurol       Date:  2020-11-07       Impact factor: 5.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.